SNT 5.00% 4.2¢ syntara limited

Ann: Pharmaxis Submits US New Drug Application fo, page-2

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 25 Posts.
    re: Ann: Pharmaxis Submits US New Drug Applic... I would anticipate FDA approval by Christmas at the latest thanks to the Prescription Drug User Fee Act. PDUFA dates are deadlines for the FDA to approve new drug. The FDA is normally given 10 months to review new drugs. If a drug is selected for priority review then 6 months is allotted. These times begin from the date a NDA is submitted.
 
watchlist Created with Sketch. Add SNT (ASX) to my watchlist
(20min delay)
Last
4.2¢
Change
0.002(5.00%)
Mkt cap ! $57.67M
Open High Low Value Volume
4.0¢ 4.3¢ 4.0¢ $48.01K 1.160M

Buyers (Bids)

No. Vol. Price($)
3 1025000 3.9¢
 

Sellers (Offers)

Price($) Vol. No.
4.2¢ 461843 2
View Market Depth
Last trade - 16.10pm 15/11/2024 (20 minute delay) ?
SNT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.